explore -WSS

explore

author：explore 2025-09-02 05:48:08 - browse：58

Surgeons look over an x-ray monitor showing an implanted pacemaker — coverage from STAT — Adobe

In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief.

“One classmate kept asking me, are you sure?” Ji said. “I think he asked me twice. Then he went on his phone to check to see if it was actually true.”

Ji was sure. She had spent two years before going to medical school working as a policy analyst for Rita Redberg and Sanket Dhruva, medical safety experts at the University of California, San Francisco. In a recent national survey published by the UCSF team in Health Affairs, Ji learned that it’s not just her classmates who may have misconceptions about the FDA — only 17% of physicians surveyed felt they understood the FDA’s device approval process. Around 41% felt they understood the drug side.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： As health system earnings go up, health insurance stocks go down

WSS

New case study details death in closely watched Alzhiemer's trial

Brain MRIs reveal impact of 'toxic stress' on Black children

Community addresses injustice for Long Island mothers

Listen: PBM conflicts, RSV vaccines, & the future of flu season

How a small hospital in rural Puerto Rico survived Hurricane Maria

Brain 'hot spot' may explain why African Americans feel greater pain

focus

explore

knowledge

Medicare details structure of new drug price negotiation program

BIO to announce reorganization, senior leaders expected to depart

Supreme Court strikes down use of affirmative action

Did the public have the right to know Arthur Ashe had AIDS?

Medicare details structure of new drug price negotiation program

Brain MRIs reveal impact of 'toxic stress' on Black children

Duchenne breakthrough therapy leaves behind pioneering families

7 people shot in DC, police say

At least 13 dead in Texas as scorching temps continue

The creative science of coining drug names

knowledge

As health system earnings go up, health insurance stocks go down

Chemotherapy before breast cancer surgery might fuel metastasis

AI for drug discovery: Experts on separating hype from reality

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

The creative science of coining drug names

Grail is spending more than ever lobbying Congress

hotspot

hotspot

explore

focus